QuidelOrtho
QDEL
349 hedge funds and large institutions have $4.61B invested in QuidelOrtho in 2021 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 141 increasing their positions, 115 reducing their positions, and 95 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 115
3.42% more ownership
Funds ownership: 82.01% → 85.43% (+3.4%)
10% less funds holding
Funds holding: 386 → 349 (-37)
25% less capital invested
Capital invested by funds: $6.18B → $4.61B (-$1.57B)
36% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 95
37% less call options, than puts
Call options by funds: $103M | Put options by funds: $163M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
Top Sellers
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$124M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$71.3M |
| 3 |
Holocene Advisors
New York
|
-$58.4M |
| 4 |
FAM
Fred Alger Management
New York
|
-$54.9M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$46.9M |
QDEL Hedge Fund Activity: Q1 2021 in Review
349 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in QuidelOrtho (QDEL) for Q1 2021, worth a combined $4.61B — down 25% from $6.18B a quarter earlier.
Sellers outnumbered buyers: 95 funds closed out of QDEL and 61 opened new positions — a net loss of 34 holders — while 115 trimmed existing stakes and 141 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $399M. The largest seller was Oracle Investment Management, cutting an estimated $124M.
- 349 institutional investors held QuidelOrtho (QDEL) as of Q1 2021, down from 386 in Q4 2020.
- Funds reported $4.61B of QuidelOrtho stock for Q1 2021, down 25% quarter-over-quarter.
- 61 funds opened new QuidelOrtho positions in Q1 2021 and 95 closed out, a net change of -34 holders.
- The largest QuidelOrtho buyer in Q1 2021 was T. Rowe Price Associates, an estimated $399M added.
- The largest QuidelOrtho seller in Q1 2021 was Oracle Investment Management, an estimated $124M sold.
Based on aggregated 13F filings for Q1 2021.